Drugs / FDX104
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02239731 | Oct 2014 → Oct 2015 | toxic dermatosis | Vyne Therapeutics Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FDX104 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02239731 ↗ |
| Route | Topical | “Treatment (twice-daily topical FDX104 4% on one side of the face and vehicle foam on the other for 5 weeks)” PMID 30607677 ↗ Jan 2019 |